Kynam Capital Discloses 1.23M ADSs (13.97%) in Burning Rock
Burning Rock Biotech Ltd Schedule 13G/A (Amendment No. 4) reports that Kynam Capital Management, LP (with related filers) beneficially owns 1,227,555 ADSs, representing 13.97% of the class.
Rhea-AI Filing Summary
Burning Rock Biotech Ltd Schedule 13G/A (Amendment No. 4) reports that Kynam Capital Management, LP (with related filers) beneficially owns 1,227,555 ADSs, representing 13.97% of the class. The filing lists shared voting and dispositive power of 1,227,555 ADSs for Kynam entities and Yue Tang. The signatures are dated 05/15/2026.
Positive
- None.
Negative
- None.
Insights
Large passive stake disclosed: 1,227,555 ADSs (13.97%).
The filing shows Kynam Capital Management, LP and affiliated entities report shared voting and dispositive power over 1,227,555 ADSs, equal to 13.97%. This indicates a sizable disclosed position under Schedule 13G/A reporting conventions.
The filing is an amendment (Amendment No. 4) with signatures dated 05/15/2026. Future amendments or Form 13D would change characterization; timing and change drivers are not stated in the excerpt.
Shared control signals entity-level ownership, not sole control.
All three filers list 0 sole voting power and 1,227,555 shared voting and dispositive power, indicating coordinated ownership through affiliated entities rather than individual sole control.
Filers include a managing member signature by Yue Tang on 05/15/2026. Changes to voting arrangements or additional filings would be disclosed in subsequent amendments.
Key Figures
Key Terms
Beneficially owned regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Kynam Capital report in Burning Rock Biotech (BNR)?
Who are the filers listed on the Schedule 13G/A for BNR?
What class of security is reported in the filing for BNR?
When was this Schedule 13G/A amendment signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.